231 related articles for article (PubMed ID: 4147164)
21. Central transmitter involvement in LON-954-induced tremorogenesis.
Coward DM; Doggett NS; Thomas JE
Neuropharmacology; 1977; 16(7-8):479-84. PubMed ID: 144244
[No Abstract] [Full Text] [Related]
22. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain.
Leonard BE
Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):242-53. PubMed ID: 4363855
[No Abstract] [Full Text] [Related]
23. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain.
Davis JN; Carlsson A
J Neurochem; 1973 Oct; 21(4):783-90. PubMed ID: 4148239
[No Abstract] [Full Text] [Related]
24. Antagonism of the acute electroencephalographic and behavioral effects of morphine in the rat by depletion of brain biogenic amines.
Colasanti B; Khazan N
Neuropharmacology; 1973 May; 12(5):463-9. PubMed ID: 4267733
[No Abstract] [Full Text] [Related]
25. Actions of atropine, hemicholinium-3, and physostigmine on chlorpromazine-induced changes in rat brain monoamines.
Bhatnagar SP
Can J Physiol Pharmacol; 1974 Jun; 52(3):500-7. PubMed ID: 4152758
[No Abstract] [Full Text] [Related]
26. Effect of yohimbine on brain monoamines: an in vivo study.
Brannan T; Martinez-Tica J; Yahr MD
J Neural Transm Park Dis Dement Sect; 1991; 3(2):81-7. PubMed ID: 1716906
[TBL] [Abstract][Full Text] [Related]
27. Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels.
Buxbaum DM; Yarbrough GG; Carter ME
J Pharmacol Exp Ther; 1973 May; 185(2):317-27. PubMed ID: 4267383
[No Abstract] [Full Text] [Related]
28. Measurements of monoamine synthesis and turnover with special reference to 5-hydroxytryptamine.
Carlsson A
Adv Biochem Psychopharmacol; 1974; 10():75-81. PubMed ID: 4152552
[No Abstract] [Full Text] [Related]
29. Role of serotoninergic and adrenergic mechanisms in the action of prominal.
Nowakowska E; Godlewski J
Acta Physiol Pol; 1979; 30(5-6):581-7. PubMed ID: 93847
[TBL] [Abstract][Full Text] [Related]
30. Brain monoamine levels and E1 mouse convulsions.
Hiramatsu M
Folia Psychiatr Neurol Jpn; 1981; 35(3):261-6. PubMed ID: 6173293
[TBL] [Abstract][Full Text] [Related]
31. The effects of 3- -dimethylaminopropyl-3-phenylphthalide (I.C.I. 53,165) on brain monoamines and their precursors.
Leonard BE
Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):94-107. PubMed ID: 5072195
[No Abstract] [Full Text] [Related]
32. Modification of electroshock convulsive responses and thresholds in neonatal rats after brain monoamine reduction.
London ED; Buterbaugh GG
J Pharmacol Exp Ther; 1978 Jul; 206(1):81-90. PubMed ID: 307060
[TBL] [Abstract][Full Text] [Related]
33. [Central monoaminergic mechanisms and generalized convulsions (review)].
Arushanian EB
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(3):457-63. PubMed ID: 817551
[No Abstract] [Full Text] [Related]
34. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
Ahlenius S
Brain Res; 1974 Mar; 69(1):57-65. PubMed ID: 4150408
[No Abstract] [Full Text] [Related]
35. Evidence of a role for brain monoamines in ethanol dependence.
Griffiths PJ; Littleton JM; Oritz A; Brownlee G
Br J Pharmacol; 1973 Jun; 48(2):354P. PubMed ID: 4147432
[No Abstract] [Full Text] [Related]
36. Studies related to the cholinergic influence on the accumulation and disappearance of monoamines in rat brain.
Bhatnagar SP
Can J Physiol Pharmacol; 1973 Dec; 51(12):893-9. PubMed ID: 4777240
[No Abstract] [Full Text] [Related]
37. Interactions of imipramine and synthesis inhibitors on biogenic amines.
Friedman E; Shopsin B; Goldstein M; Gershon S
J Pharm Pharmacol; 1974 Dec; 26(12):995-6. PubMed ID: 4156872
[No Abstract] [Full Text] [Related]
38. The inhibition of (3H) biogenic amine accumulation into rat brain tissue slices by various tryptamine derivatives.
Heikkila RE; Cohen G
Res Commun Chem Pathol Pharmacol; 1974 Mar; 7(3):539-47. PubMed ID: 4824828
[No Abstract] [Full Text] [Related]
39. Monoaminergic control of episodic growth hormone secretion in the rat: effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine, and haloperidol.
Edén S; Bolle P; Modigh K
Endocrinology; 1979 Aug; 105(2):523-9. PubMed ID: 156637
[TBL] [Abstract][Full Text] [Related]
40. Paradoxical blockade by p-chlorophenylalanine of 5-hydroxytryptophan facilitatory actions on spinal reflexes.
Taber CA; Anderson EG
J Pharmacol Exp Ther; 1973 Nov; 187(2):229-38. PubMed ID: 4356011
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
